In some countries, this medicine may only be approved for veterinary use.
In the US, Methyltestosterone (methyltestosterone systemic) is a member of the drug class androgens and anabolic steroids and is used to treat Breast Cancer - Palliative, Delayed Puberty - Male, Hypogonadism - Male and Postpartum Breast Pain.
US matches:
- Methyltestosterone
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
G03BA02,G03EK01
CAS registry number (Chemical Abstracts Service)
0000058-18-4
Chemical Formula
C20-H30-O2
Molecular Weight
302
Therapeutic Category
Androgen
Chemical Name
Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17ß)-
Foreign Names
- Methyltestosteronum (Latin)
- Methyltestosteron (German)
- Méthyltestostérone (French)
- Metiltestosterona (Spanish)
Generic Names
- Methyltestosterone (OS: BAN)
- Méthyltestostérone (OS: DCF)
- Metiltestosterone (OS: DCIT)
- NSC 9701 (IS)
- Methyltestosteron (PH: Ph. Eur. 6)
- Methyltestosterone (PH: BP 2010, JP XIV, Ph. Int. 4, USP 32, Ph. Eur. 6)
- Methyltestosteronum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Afro
Casel, Turkey - Android
Valeant, United States - Enarmon
ASKA SeiyakuAsuka, Japan - Enerfa
Harasawa Seiyaku, Japan - Estratest (Methyltestosterone and Estrogens, conjugated)
Solvay, United States - Mamineurine (Methyltestosterone and Ethinylestradiol (veterinary use))
Sogeval, France - Methitest
Global, United States - Methyltestosterone
Impax, United States - Orandrone (veterinary use)
Intervet, United Kingdom - Taril (Methyltestosterone and Ethinylestradiol (veterinary use))
Omega Pharma France, France - Testred
Valeant, United States - Virilon
Star, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment